Phospholemman Deficiency in Postinfarct Hearts: Enhanced Contractility but Increased Mortality

Abstract Phospholemman (PLM) regulates [Na + ] i , [Ca 2+ ] i and contractility through its interactions with Na + ‐K + ‐ATPase (NKA) and Na + /Ca 2+ exchanger (NCX1) in the heart. Both expression and phosphorylation of PLM are altered after myocardial infarction (MI) and heart failure. We tested the hypothesis that absence of PLM regulation of NKA and NCX1 in PLM‐knockout (KO) mice is detrimental. Three weeks after MI, wild‐type (WT) and PLM‐KO hearts were similarly hypertrophied. PLM expression was lower but fractional phosphorylation was higher in WT‐MI compared to WT‐sham hearts. Left ventricular ejection fraction was severely depressed in WT‐MI but significantly less depressed in PLM‐KO‐MI hearts despite similar infarct sizes. Compared with WT‐sham myocytes, the abnormal [Ca 2+ ], transient and contraction amplitudes observed in WT‐MI myocytes were ameliorated by genetic absence of PLM. In addition, NCX1 current was depressed in WT‐MI but not in PLM‐KO‐MI myocytes. Despite improved myocardial and myocyte performance, PLM‐KO mice demonstrated reduced survival after MI. Our findings indicate that alterations in PLM expression and phosphorylation are important adaptations post‐MI, and that complete absence of PLM regulation of NKA and NCX1 is detrimental in post‐MI animals. Clin Trans Sci 2012; Volume #: 1–8